A. Corlateanu (Chisihau, Republic of Moldova), B. Cushen (Dublin 11, Ireland), B. Balbi (Veruno (NO), Italy)
Usefulness of nutrition screening tools for sarcopenia screening with chronic obstructive pulmonary disease in JAPAN
H. Nakamura (Sakaide Kagawa, Japan), N. Kita (Sakaide Kagawa, Japan), K. Tanimoto (Sakaide Kagawa, Japan), C. Kunikata (Sakaide Kagawa, Japan), T. Taoka (Sakaide Kagawa, Japan)
|  |
Association between endothelial dysfunction and nutrient consumption in patients with chronic obstructive pulmonary disease and heart failure.
C. Méndez-Chávez (Mexico, Mexico), A. Orea-Tejeda (Mexico, Mexico), D. González-Islas (Mexico, Mexico), R. Sánchez Santillán (Mexico, Mexico), C. Olivo-Villalobos (Mexico, Mexico), G. Dávila-Said (Mexico, Mexico), V. Paláez-Hernández (Mexico, Mexico), K. Balderas-Muñoz (Mexico, Mexico), A. Velázquez-Montero (Mexico, Mexico), M. Rivera-Rodríguez (Mexico, Mexico), L. Castillo-Aguilar (Mexico, Mexico), L. Hernández-Urquieta (Mexico, Mexico)
|  |
A comparison of muscle dysfunction in patients with chronic obstructive pulmonary disease and healthy subjects
R. Djebaili (Batna , Algeria), R. Heddane (Batna , Algeria), R. Direche (Batna , Algeria), M. Oulmi (Batna , Algeria), A. Djebbar (Batna , Algeria)
| |
Nutrition status and comorbidities in patients with severe COPD.
E. Voláková (Olomouc, Czech Republic), J. Zatloukal (Olomouc, Czech Republic), V. Koblizek (Hradec Kralove, Czech Republic), M. Svoboda (Brno, Czech Republic), P. Popelkova (Ostrava, Czech Republic), M. Plutinsky (Brno, Czech Republic), K. Brat (Brno, Czech Republic), B. Novotna (Praha, Czech Republic), P. Safranek (Plzen, Czech Republic), T. Dvorak (Mlada Boleslav, Czech Republic), D. Rakita (Praha, Czech Republic), M. Sipkova (Liberec, Czech Republic), R. Simek (Zlin, Czech Republic), E. Kocova (Hradec Kralove, Czech Republic), M. Kopecky (Hradec Kralove, Czech Republic), L. Heribanova (Praha, Czech Republic), P. Musilova (Jihlava, Czech Republic), B. Snelerova (Usti nad Labem, Czech Republic), Z. Liptakova (Ceske Budejovice, Czech Republic), K. Neumannova (Olomouc, Czech Republic), Z. Zbozinkova (Brno, Czech Republic)
| |
Does Nutritional Risk Screening 2002 correlate with dyspnea status of patients with GOLD stage 3-4 chronic obstructive pulmonary disease: a Cohort study.
N. Ogan (Ankara, Turkey), F. Bodur Yildirim (Ankara, Turkey), B. Süzen (Ankara, Turkey), A. Baha (Ankara, Turkey), E. Akpinar (Ankara, Turkey)
| |
Nutritional status changing in COPD – Follow-up Platino Study
O. Nascimento (São Paulo, Brazil), M. Gazzotti (São Paulo, Brazil), A. Luize (São Paulo, Brazil), G. Moreira (São Paulo, Brazil), B. Manzano (São Paulo, Brazil), A. Menezes (São Paulo, Brazil), R. Perez-Padilla (Mexico City, Mexico), A. Muiño (Montevideo, Uruguay), M. López-Varela (Montevideo, Uruguay), M. Montes De Oca (Caracas Paulo, Venezuela), J. Jardim (São Paulo, Brazil)
| |
Body composition in chronic obstructive pulmonary disease and heart failure
L. HernáNdez-Urquieta (Mexico City, Mexico), C. CháVez-MéNdez (Mexico City, Mexico), A. Orea-Tejeda (Mexico City, Mexico), D. GonzáLez-Islas (Mexico City, Mexico), R. Sanchez SAntillan (Mexico City, Mexico), R. HernáNdez-Zenteno (Mexico City, Mexico), G. DáVila-Said (Mexico City, Mexico), C. Olivo-Villalobos (Mexico City, Mexico), V. PeláEz-HernáNdez (Mexico City, Mexico), K. Balderas-MuñOz (Mexico City, Mexico), M. Rivera-RodríGuez (Mexico City, Mexico), L. Castillo-Aguilar (Mexico City, Mexico)
| |
Correlation between peritoneal fat and mid-thigh fat in chronic respiratory patients
L. Ciobanu (Iasi, Romania), V. Maciuc (Iasi, Romania)
| |
Role of the fat and muscle tissues in formation of the quality of life in COPD patients.
V. Poberezhets (Vinnytsia, Ukraine), Y. Mostovoy (Vinnytsia, Ukraine), H. Demchuk (Vinnytsia, Ukraine)
| |
Sleep duration is an independent determinant of metabolic impairment in COPD patients
N. Sahdev (London, United Kingdom), D. Burrage (London, United Kingdom), C. Wells (London, United Kingdom), E. Baker (London, United Kingdom)
| |
Associations between variations of adipokines, cytokines and body composition in patients with chronic obstructive pulmonary disease in one year
C. Mesquita (Botucatu, Brazil), R. Prudente (Botucatu, Brazil), C. Knaut (Botucatu, Brazil), E. Franco (Botucatu, Brazil), I. Godoy (Botucatu, Brazil), S. Tanni (Botucatu, Brazil)
| |
Does vitamin D deficiency worsen the hospital outcome in patients with acute exacerbation COPD?
M. Abdelghany (Assiut, Egypt), H. Makhlouf (Assiut, Egypt), A. Abdrabou (Assiut, Egypt), A. Abdelazeez (Assiut, Egypt)
| |
Metabolic syndrome in chronic obstructive pulmonary disease
H. Zaibi (Tunis, Tunisia), S. Maazaoui (Tunis, Tunisia), J. Ben Amar (Tunis, Tunisia), I. Laaouini (Tunis, Tunisia), S. Azzebi (Tunis, Tunisia), M. Baccar (Tunis, Tunisia), B. Dhahri (Tunis, Tunisia), H. Aouina (Tunis, Tunisia)
| |
Correlation between being underweight and the severity of COPD
l. Loued (Tunis, Tunisia), S. Toujani (Tunis, Tunisia), A. Hedhli (Tunis, Tunisia), S. Cheikhrouhou (Tunis, Tunisia), M. Mjid (Tunis, Tunisia), Y. Ouahchi (Tunis, Tunisia), S. Meraii (Tunis, Tunisia)
| |
Sedentary behaviour is associated with worse cardiometabolic profiles in COPD patients, irrespective of moderate intensity physical activity
D. Burrage (London, United Kingdom), C. Wells (London, United Kingdom), E. Baker (London, United Kingdom)
| |
Sarcopenia index correlates with COPD clinical outcomes.
C. Amado Diago (Santander, Spain), B. Abascal Bolado (Santander, Spain), J. AgüEro Calvo (Santander, Spain), B. Durantes (Santander, Spain), M. Ruiz De Infante (Santander, Spain), A. Guerra (Santander, Spain), M. GarcíA-Unzueta (Santander, Spain), B. Alio LavíN (Santander, Spain), E. Arnaiz-GarcíA (Salamanca, Spain)
| |
Clinical outcome and cost-effectiveness of 1-year nutritional intervention program in COPD
M. van Beers (Maastricht, Netherlands), M. Rutten-Van Molken (Rotterdam, Netherlands), C. Van De Bool (Maastricht, Netherlands), M. Boland (Rotterdam, Netherlands), S. Kremers (Maastricht, Netherlands), F. Franssen (Horn, Netherlands), A. Van Helvoort (Utrecht, Netherlands), H. Gosker (Maastricht, Netherlands), E. Wouters (Maastricht, Netherlands), A. Schols (Maastricht, Netherlands)
| |
Change of inhaled medications during hospital admissions for acute exacerbation of COPD
V. Ridley (London , United Kingdom), E. Barter (London , United Kingdom), C. Davey (London , United Kingdom), R. Singh (London , United Kingdom), J. Simpson (London , United Kingdom)
| |
Chronic obstructive pulmonary disease patients: pilot project of 90-day monitoring
A. Oliva Ramos (Madrid, Spain), J. Terán Tinedo (Madrid, Spain), V. Gallo González (Madrid, Spain), E. Ojeda Castillejo (Madrid, Spain), J. Vargas Espinal (Madrid, Spain), L. Puente Maestu (Madrid, Spain), J. De Miguel Díez (Madrid, Spain)
| |